SIM
IRWD icon

SummerHaven Investment Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

SummerHaven Investment Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-72,030
Closed -$470K – 238
2024
Q2 		$470K Buy
72,030
+2,491
+4% +$17.6K 0.31% 164
2024
Q1 		$606K Buy
69,539
+794
+1% +$9.63K 0.38% 159
2023
Q4 		$786K Buy
68,745
+980
+1% +$9.69K 0.5% 99
2023
Q3 		$653K Buy
+67,765
New +$664K 0.48% 119

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SummerHaven Investment Management's IRWD Position: Q3 2024 in Review

SummerHaven Investment Management sold out of Ironwood Pharmaceuticals (IRWD) in Q3 2024, closing a stake of 72,030 shares — an estimated $470K sold.

SummerHaven Investment Management first reported a position in IRWD in Q3 2023 and held it in 4 quarters. The position peaked at $786K in Q4 2023. 221 funds tracked by Wall St. Rank hold IRWD as of Q3 2024.

  • SummerHaven Investment Management reported no remaining Ironwood Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • SummerHaven Investment Management sold 72,030 Ironwood Pharmaceuticals shares in Q3 2024, an estimated $470K.
  • SummerHaven Investment Management first reported a position in Ironwood Pharmaceuticals in Q3 2023 and held it in 4 quarters.
  • SummerHaven Investment Management's Ironwood Pharmaceuticals position peaked at $786K in Q4 2023.
  • 221 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2024.

Based on SummerHaven Investment Management's 13F filing for Q3 2024, filed 16 Oct 2024.